ZURICH, Nov 16 (Reuters) - Swiss contract drug manufacturer Lonza's (LONN.S), opens new tabplants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback